Dr. Ranga Godavarti is currently a Vice President in the Bioprocess Research and Development group at Pfizer. His group is responsible for the development, characterization, and technology transfer of upstream and downstream processes for large molecules (proteins and vaccines) in early and late stages of development.
Prior to joining Pfizer (formerly Wyeth) in 1997, Ranga received his Master’s degree in Chemical Engineering Practice and a Ph.D in Chemical Engineering from the Massachusetts Institute of Technology (MIT). He has authored several publications and has been...Read more